- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
30 Adhd Trials near Connecticut
Power is an online platform that helps thousands of Adhd patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerCentanafadine for ADHD
Trial Details
Key Eligibility Criteria
680 Participants Needed
EWM Training for ADHD
Trial Details
Key Eligibility Criteria
130 Participants Needed
Psilocybin for Depression
Trial Details
Key Eligibility Criteria
50 Participants Needed
Financial Capability Support for Mental Health Issues
Trial Details
Key Eligibility Criteria
238 Participants Needed
Community Treatment for Infectious Diseases and Opioid Use Disorder
Trial Details
Key Eligibility Criteria
600 Participants Needed
Culturally Tailored Recovery Programs for Substance Abuse
Trial Details
Key Eligibility Criteria
525 Participants Needed
Work-Focused Program for Substance Use Disorders
Trial Details
Key Eligibility Criteria
103 Participants Needed
Nicotine Thresholds for Smoking Addiction
Trial Details
Key Eligibility Criteria
36 Participants Needed
Nicotine Dosing for Nicotine Addiction
Trial Details
Key Eligibility Criteria
70 Participants Needed
Change4Better App for Gambling Addiction
Trial Details
Key Eligibility Criteria
128 Participants Needed
E-Cigarette Flavors for Electronic Cigarette Use
Trial Details
Key Eligibility Criteria
60 Participants Needed
New Opioid Packaging for Opioid Use Disorder
Trial Details
Key Eligibility Criteria
352 Participants Needed
Specialized Post-Incarceration Care for Opioid Addiction
Trial Details
Key Eligibility Criteria
400 Participants Needed
E-liquid Coolants for Nicotine Addiction
Trial Details
Key Eligibility Criteria
66 Participants Needed
Synthetic Cannabinoids for Substance Use Disorders
Trial Details
Key Eligibility Criteria
15 Participants Needed
Intensive Day Monitoring for Cannabis Use
Trial Details
Key Eligibility Criteria
60 Participants Needed
Motivational Conversation for Substance Use
Trial Details
Key Eligibility Criteria
50 Participants Needed
E-cigarettes vs Nicotine Pouches for Smoking Cessation
Trial Details
Key Eligibility Criteria
256 Participants Needed
Integrated Harm Reduction for Substance Use Disorders
Trial Details
Key Eligibility Criteria
200 Participants Needed
Fathers for Change vs. Individual Drug Counseling
Trial Details
Key Eligibility Criteria
280 Participants Needed
Why Other Patients Applied
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Extended Release Buprenorphine for Opioid Use Disorder
Trial Details
Key Eligibility Criteria
344 Participants Needed
LDART for Stimulant Use Disorder
Trial Details
Key Eligibility Criteria
40 Participants Needed
Varenicline for Vaping
Trial Details
Key Eligibility Criteria
326 Participants Needed
Tralokinumab for Atopic Hand Eczema
Trial Details
Key Eligibility Criteria
235 Participants Needed
M2VA Pain Care Pathway for Pain
Trial Details
Key Eligibility Criteria
1800 Participants Needed
Indoor Air Quality Monitor for Smoking Cessation
Trial Details
Key Eligibility Criteria
10 Participants Needed
Written Exposure Therapy for PTSD in Veterans with Substance Use Disorders
Trial Details
Key Eligibility Criteria
170 Participants Needed
THC + CBD for Opioid Use Disorder and Chronic Pain
Trial Details
Key Eligibility Criteria
147 Participants Needed
Physician-focused Behavioral Intervention for Prostate Cancer Imaging
Trial Details
Key Eligibility Criteria
58 Participants Needed
LDART for Alcoholism
Trial Details
Key Eligibility Criteria
80 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Adhd clinical trials in Connecticut pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Adhd clinical trials in Connecticut work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Adhd trials in Connecticut 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Connecticut for Adhd is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Connecticut several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Adhd medical study in Connecticut?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Adhd clinical trials in Connecticut?
Most recently, we added Motivational Conversation for Substance Use, LDART for Stimulant Use Disorder and LDART for Alcoholism to the Power online platform.
How to manage ADHD without Adderall?
Think of ADHD care without Adderall as three pillars: 1) proven skills training such as cognitive-behavioral therapy or parent/teacher coaching, which meta-analyses show can meaningfully cut inattentive and impulsive symptoms; 2) daily habits that boost brain chemicals—consistent aerobic exercise, 7-9 hours of sleep, and a balanced, low-sugar diet—each backed by research to modestly improve focus; 3) targeted add-ons (omega-3 fish-oil supplements, mindfulness practice, or professionally guided neurofeedback) that have small but credible benefits for some people. Work with a clinician to combine, test, and adjust these pieces every few months so you know what is actually helping and can add non-stimulant medicines later if needed.
Are we over diagnosing ADHD?
Rates of ADHD diagnosis have climbed, and studies confirm that some children—especially the youngest in a class or from more advantaged families—get the label and medication they may not truly need. At the same time, girls, adults, and many minorities with real symptoms are often missed, so the issue is less “too much” diagnosis overall and more “diagnosis in the wrong people.” Asking for a full evaluation that checks symptoms in several settings and rules out sleep, mood, or learning problems is the best safeguard against both mistakes.
What is the latest research on ADHD?
Recent work is mapping ADHD on two fronts: cause and treatment. On the biology side, a 2023 genome-wide study involving >40 000 people pinpointed 30+ gene regions, MRI scans show disrupted communication between attention- and reward-circuits, and several studies find distinct gut-bacteria patterns in both kids and adults—together suggesting ADHD arises from a mix of genes, brain-network wiring and (still-early) gut influences. Translating this, clinicians now have newer options beyond classic stimulants—FDA-approved viloxazine XR, long-acting patches, the prescription video-game EndeavorRx, and small but promising trials of neurofeedback and cognitive training—so ask your doctor about standard medications plus these emerging tools that may soon allow more personalized care.
Does Johnny Depp have ADHD?
There is no credible public record—interview, court document, or medical statement—showing that Johnny Depp has been formally diagnosed with ADHD; the claim stems from unsourced online lists that repeat each other. Until Depp or a qualified clinician confirms otherwise, any statement that he “has ADHD” should be treated as unverified speculation; if you need information about ADHD, rely on a licensed health professional, not celebrity rumors.
What is the 80 20 rule ADHD?
For someone with ADHD, the 80/20 rule means spotting the 20 % of tasks or habits that create about 80 % of your desired results—then protecting time and attention to do those first, ideally when your medication or energy is at its peak. This cuts overwhelm because you give yourself permission to ignore low-impact busywork and instead break the high-impact tasks into small, doable steps (using timers, alerts, or an accountability partner). Think of it as a focusing lens, not a cure; pair it with your regular ADHD treatments and adjust the “vital 20 %” as your goals change.
Is ADHD a disability?
Yes—ADHD is treated as a disability when the symptoms are strong enough to “substantially limit” everyday activities like focusing, learning, or working, which is exactly how U.S. laws such as the ADA, Section 504, and Social Security define disability. A diagnosis alone isn’t enough; you need documentation that the condition is causing real-world problems, after which schools, employers, or benefit programs must consider reasonable supports (extra time, quiet workspace, flexible scheduling, etc.). If you think ADHD is holding you back, gather medical records and examples of how it affects your tasks and formally ask for accommodations or benefits under the relevant program.
What makes ADHD people happy?
Studies show that people with ADHD feel happiest when four things line up: (1) their core symptoms are tamed with medication and/or ADHD-specific therapy, (2) predictable routines, reminders, exercise, and good sleep cut daily chaos, (3) they spend real time in activities that match their high interests and creativity, and (4) they’re surrounded by family, friends, or support groups that understand ADHD rather than shame it. Put simply: treat the symptoms, externalize organization, lean into your passions, and stay connected to people who “get” you—those combined levers consistently raise quality-of-life scores for both kids and adults with ADHD.
How much weight did you lose on ADHD medication?
Weight loss on stimulant ADHD medicines is usually modest and highly individual—clinical trials show average drops of about 3–5 lb (1–2 kg) in the first month and roughly 6–10 lb (3–4 kg) over the first 3–6 months, with only one-third of people losing more than 5 % of their starting weight before the effect levels off. Weigh yourself (or your child) weekly; if you see more than a 10 % fall from baseline or a slowdown in growth, talk with the prescriber about dose timing, nutrition strategies, or switching to a non-stimulant option.
What makes ADHD worse in adults?
Anything that further strains the brain’s self-regulation system can flare adult ADHD: lack of sleep or exercise, chronic stress, unmanaged anxiety/depression, inconsistent medication or substance use, hormonal shifts, and chaotic, screen-heavy environments. Focus on the controllables—protect 7-9 h of sleep, move daily, eat regular balanced meals, keep spaces and schedules simple, treat co-existing mood issues, and take medication exactly as prescribed—then review persisting problems with your clinician.
Is there still ADHD med shortage?
Yes—into 2024 many pharmacies still report spot shortages of popular stimulant ADHD medicines, especially immediate-release Adderall, several methylphenidate/Concerta generics, and some Vyvanse doses, because factory slow-downs and federally capped production haven’t kept up with rising prescriptions. Availability varies week-to-week and by location, so call a few pharmacies early, ask if a different strength or brand is in stock, and have your prescriber ready to adjust the prescription or discuss a short-term non-stimulant alternative if needed.